MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ACAD had -$142,819K decrease in cash & cash equivalents over the period. $105,146K in free cash flow.

Cash Flow Overview

Change in Cash
-$142,819K
Free Cash flow
$105,146K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Sale and maturity of investment ...
    • Net income (loss)
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Purchases of investment securiti...
    • Deferred income taxes (including...
    • Payment of milestone and conting...
    • Others

Cash Flow
2025-12-31
Net income (loss)
391,000
Stock-based compensation
52,135
Amortization of premiums and accretion of discounts on investment securities
5,424
Amortization of intangible assets
10,889
Gain on sale of non-financial asset
0
Gain on strategic investment
0
Depreciation
871
Loss on sale of investment securities
0
Deferred income taxes (including benefit from valuation allowance)
-249,879
Accounts receivable, net
22,718
Interest and other receivables
20,818
Inventory
18,197
Prepaid expenses and other current assets
3,845
Operating lease right-of-use assets
-8,667
Other assets
2,856
Accounts payable
-5,289
Accrued liabilities
-19,265
Operating lease liabilities
-6,516
Long-term liabilities
1,081
Net cash provided by operating activities
109,836
Purchases of investment securities
692,565
Sale and maturity of investment securities
493,529
Proceeds from sale of non-financial asset
0
Proceeds from sales of strategic investment
0
Net purchases of property and equipment
4,690
Payment of milestone and contingent payments in connection with asset acquisition
98,838
Net cash (used in) provided by investing activities
-302,564
Proceeds from issuance of common stock, net of issuance costs
49,883
Net cash provided by financing activities
49,883
Effect of exchange rate changes on cash
26
Net (decrease) increase in cash, cash equivalents and restricted cash
-142,819
Beginning of period
328,359
End of period
185,540
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net income (loss)$391,000K Proceeds from issuance ofcommon stock, net of...$49,883K Stock-based compensation$52,135K Amortization of intangibleassets$10,889K Operating leaseright-of-use assets-$8,667K Long-term liabilities$1,081K Depreciation$871K Net cash provided byoperating activities$109,836K Net cash provided byfinancing activities$49,883K Effect of exchange ratechanges on cash$26K Canceled cashflow$354,807K Net (decrease)increase in cash, cash...-$142,819K Canceled cashflow$159,745K Sale and maturity ofinvestment securities$493,529K Deferred income taxes(including benefit from...-$249,879K Accounts receivable, net$22,718K Interest and otherreceivables$20,818K Accrued liabilities-$19,265K Inventory$18,197K Operating leaseliabilities-$6,516K Amortization of premiums andaccretion of discounts on...$5,424K Accounts payable-$5,289K Prepaid expenses andother current assets$3,845K Other assets$2,856K Net cash (used in)provided by investing...-$302,564K Canceled cashflow$493,529K Purchases of investmentsecurities$692,565K Payment of milestone andcontingent payments in...$98,838K Net purchases ofproperty and equipment$4,690K

ACADIA PHARMACEUTICALS INC (ACAD)

ACADIA PHARMACEUTICALS INC (ACAD)